Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01625078
Other study ID # C.A.657
Secondary ID
Status Completed
Phase Phase 2
First received March 23, 2012
Last updated May 28, 2014
Start date March 2012
Est. completion date June 2013

Study information

Verified date May 2014
Source University College Hospital Galway
Contact n/a
Is FDA regulated No
Health authority Ireland: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

The investigators wish to accumulate initial data on the performance and safety of the Baska mask in paediatric patient population.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date June 2013
Est. primary completion date June 2013
Accepts healthy volunteers No
Gender Both
Age group 8 Years to 16 Years
Eligibility Inclusion Criteria:

- consent

- BMI 15-35

- weight over 30kg or age 8-16 yrs

- non-urgent surgery of planned duration up to 2 hrs

Exclusion Criteria:

- neck pathology

- previous or anticipated problems with the upper GI or upper airway

- increased risk of gastric aspiration

- expected difficult airway

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Baska Mask Efficacy and Safety in Children

Intervention

Device:
Placement and use of Baska mask
Use of Baska mask as a supraglottic airway during general anesthesia

Locations

Country Name City State
Ireland Galway University Hospitals Galway

Sponsors (1)

Lead Sponsor Collaborator
John Laffey

Country where clinical trial is conducted

Ireland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Device insertion success rate within 30 minutes of induction of general anesthesia No
Primary device airway leak pressure the airway l;eak pressure is defined as the plateau airway pressure measured while the patient is apnoeic with the APL valve of the anaesthetic machine set to 35 cm H2O and the fresh gas flow set to 6 L/min within 10 minutes of successful device placement No
Secondary airway stability the tidal volumes will be measured in different head positions and the leak fractions calculated. within 30 minutes of device placement No
Secondary ease of device placement the ease of device placement will be evaluated by Visual Analogue Scale within 30 minutes of induction of general anesthesia No
Secondary complications during the anesthetic complications that may be related to the device use will be monitored including but not limited to desaturation episodes, laryngospasm, loss of airway, need to switch ot alternative device, blood staining on mask removal sore throat, dysphonia, dysphagia from the start of device insertion untill discharge from recovery, an expected average of 2 hours Yes